It was originally developed and approved for the management of type 2 diabetes and is also FDA-approved under specific indications for chronic weight management in certain patients
Alex Tatem walks through retatrutide's mechanism, Phase 3 results, and what an injector-based delivery system will likely mean in practice
When exploring cost-effective options for prescription medications, consider reliable cash-pay pharmacies that offer transparent pricing
A phase 2 clinical trial demonstrates that #retatrutide, a triple agonist of the GIP, GLP-1, and glucagon receptors, results in up to 82% reduction in liver fat #MASLD @ArunJSanyalVCU nature.com Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver
Image courtesy of the Marc Lab, University of Utah
Cinnamon Extract (2.75mg) associated with minor blood sugar regulation, but again, studies use grams , not milligrams